Cataract Surgery Device Market Size, Share, Growth, and Industry Analysis, By Type (Intraocular Lens,Foldable IOL,Others), By Application (Hospital,Clinic,Others), Regional Insights and Forecast to 2035

Cataract Surgery Device Market Overview

The global Cataract Surgery Device Market is forecast to expand from USD 4415.33 million in 2026 to USD 4604.75 million in 2027, and is expected to reach USD 6443.77 million by 2035, growing at a CAGR of 4.29% over the forecast period.

The Cataract Surgery Device Market is witnessing significant expansion, driven by the rising number of cataract procedures performed globally, which exceed 28 million annually, with more than 60% of surgeries requiring advanced phacoemulsification systems. Approximately 35% of all ophthalmic devices sold globally are related to cataract procedures, showing strong penetration in hospital and clinic setups. Over 70% of surgical patients are aged above 60, reflecting the aging population trend fueling demand. With nearly 45% of patients opting for premium intraocular lenses, the market shows strong diversification across device categories. Additionally, over 80% of ophthalmologists in developed countries prefer advanced devices, highlighting growing adoption.

In the United States, cataract surgeries exceed 4 million procedures annually, representing nearly 15% of the global share. More than 40% of ophthalmic equipment sales in the USA are linked directly to cataract procedures. Over 55% of hospitals and 65% of ambulatory surgical centers in the USA rely on modern phacoemulsification systems. Nearly 47% of patients choose advanced intraocular lenses for better post-surgical outcomes, while 30% of clinics report increased demand for femtosecond laser-assisted cataract surgery devices. The USA market accounts for over 38% of North America’s cataract-related device consumption.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Over 72% of global cataract cases are linked to aging populations, with 65% of demand stemming from patients aged 60 years and above.
• Major Market Restraint: Nearly 48% of smaller hospitals cite high device costs as a restraint, with 52% relying on older equipment.
• Emerging Trends: More than 37% of new surgeries use femtosecond laser systems, while 44% integrate advanced digital imaging tools.
• Regional Leadership: North America holds 39% share of device usage, while Europe accounts for 31% and Asia-Pacific contributes 25%.
• Competitive Landscape: The top five manufacturers control 62% of market share, with leading players capturing individual shares above 14% each.
• Market Segmentation: Intraocular lenses represent 52% of sales, phacoemulsification devices 34%, and femtosecond lasers 14%.
• Recent Development: Over 28% of device innovations since 2023 focus on AI integration, while 33% target patient comfort and reduced surgical time.

Cataract Surgery Device Market Latest Trends

The Cataract Surgery Device Market trends highlight increasing adoption of femtosecond laser technology, with more than 40% year-on-year growth in premium device installations across hospitals. Approximately 33% of ophthalmology centers worldwide have upgraded their phacoemulsification systems in the last two years. A shift toward premium intraocular lenses is evident, with 49% of patients choosing multifocal or toric lenses, compared to only 27% five years ago. Furthermore, 55% of ophthalmologists report increased demand for AI-driven diagnostics linked to cataract surgeries. By 2025, nearly 46% of surgeries are expected to incorporate robotic assistance, and 60% of surgeons prefer devices that reduce procedure time by 20% or more. With Asia-Pacific seeing a 28% increase in adoption of advanced cataract devices, regional growth patterns further reflect robust demand. In Europe, 31% of hospitals report transitioning to advanced lens implant systems. These statistics underline a global shift towards efficiency and precision in cataract surgery devices.

Cataract Surgery Device Market Dynamics

DRIVER

"Rising demand for advanced intraocular lenses"

The Cataract Surgery Device Market is primarily driven by the increased adoption of intraocular lenses, with 52% of patients globally choosing advanced lens implants in recent years. Over 47% of ophthalmologists recommend premium lenses, while 39% of clinics report higher patient satisfaction linked to advanced options. More than 33% of surgeries today involve multifocal or toric intraocular lenses, up from 21% a decade ago. Additionally, 68% of eye care centers in developed economies prioritize the use of innovative intraocular devices to enhance surgical outcomes, fueling ongoing growth in this device segment.

RESTRAINT

"High costs of femtosecond laser systems"

One of the major restraints for the Cataract Surgery Device Market is the high cost of femtosecond laser systems, which impacts affordability for smaller clinics and hospitals. Nearly 48% of healthcare facilities in developing economies cite cost as the primary barrier. Approximately 36% of hospitals in lower-income regions continue to rely on conventional manual methods due to affordability challenges. Only 24% of ambulatory surgical centers in emerging markets can afford premium femtosecond devices. Moreover, 51% of ophthalmologists state that cost-related issues delay technology upgrades, creating a notable constraint to market expansion.

OPPORTUNITY

"Expansion in emerging markets"

A major opportunity in the Cataract Surgery Device Market is the rapid growth in emerging markets, where cataract cases account for nearly 65% of preventable blindness. More than 42% of the global cataract burden is concentrated in Asia-Pacific, with India and China together representing 29% of surgeries performed annually. Africa holds nearly 18% of untreated cataract patients, creating significant untapped opportunities. Additionally, 38% of healthcare investments in Asia-Pacific are allocated toward ophthalmic care, enhancing device penetration. With 26% annual growth in cataract-related infrastructure, emerging markets represent a substantial opportunity for device manufacturers to expand their reach.

CHALLENGE

"Shortage of skilled ophthalmic surgeons"

The Cataract Surgery Device Market faces challenges due to a shortage of skilled professionals. Nearly 41% of developing countries report fewer than 3 ophthalmologists per 100,000 population, limiting access to advanced surgeries. Approximately 27% of patients in rural regions face delayed treatments due to lack of surgical expertise. Even in developed nations, 22% of clinics report longer waiting times caused by surgeon shortages. Around 35% of global demand for cataract devices remains unmet due to staffing issues. Training programs are expanding, but only 29% of surgeons worldwide currently receive advanced training on femtosecond laser systems, creating a challenge in meeting global demand.

Segmentation Analysis

The Cataract Surgery Device Market is segmented by type and application, with intraocular lenses accounting for nearly 52% of device usage, foldable intraocular lenses representing 31%, and other devices such as femtosecond lasers and viscoelastics comprising 17%. By application, hospitals dominate with 61% of cataract procedures performed, clinics contribute 28%, and other facilities such as ambulatory surgical centers account for 11%. More than 45% of new device installations are reported in hospitals, while clinics show 37% year-on-year growth in adoption of phacoemulsification systems. This segmentation highlights the growing adoption of advanced technologies across both device types and applications.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

By Type

Intraocular Lens

Intraocular lenses dominate the Cataract Surgery Device Market, with more than 52% share globally. Approximately 47% of patients choose premium options such as multifocal or toric lenses, while 35% prefer monofocal implants. Nearly 60% of ophthalmologists recommend advanced lenses for better visual outcomes, and 41% of global hospitals report an increasing shift towards premium intraocular devices. With over 23 million implants performed annually, intraocular lenses remain the most critical device type in cataract surgeries worldwide.

Value Line: The Intraocular Lens segment holds 52% market share with steady growth, and its CAGR is 6.1%, representing the largest share of the Cataract Surgery Device Market globally.

Top 5 Major Dominant Countries in the Intraocular Lens Segment

• United States: Intraocular lens usage represents 39% of the global total, with 55% market share and a CAGR of 6.2%, making it the leading market globally.
• Germany: Accounts for 12% of intraocular lens demand, holding a 14% share regionally with CAGR of 5.8%, reflecting steady adoption in European hospitals.
• India: Represents 11% of global usage, with 18% domestic market share and CAGR of 7.3%, fueled by 2 million annual cataract procedures.
• China: Contributes 15% of global implants, maintaining 19% domestic share and CAGR of 7.8%, supported by over 3 million annual cataract surgeries.
• Japan: Holds 9% of global intraocular lens demand, with 13% market share and CAGR of 5.5%, reflecting widespread use of premium multifocal lenses.

Foldable IOL

Foldable intraocular lenses account for nearly 31% of the Cataract Surgery Device Market, with 66% of hospitals adopting them due to smaller incision sizes and faster recovery. Approximately 58% of surgeons in North America and Europe prefer foldable IOLs, while 44% of Asia-Pacific patients choose foldable options. More than 12 million procedures annually involve foldable IOLs, highlighting their growing importance. The ease of implantation and reduced post-surgery complications make them increasingly popular across both developed and emerging markets.

Value Line: The Foldable IOL segment holds 31% market share with a CAGR of 6.5%, representing strong growth across both developed and developing regions worldwide.

Top 5 Major Dominant Countries in the Foldable IOL Segment

• United States: Accounts for 33% of foldable IOL demand, holding a 41% national share and CAGR of 6.4%, with nearly 1.4 million procedures annually.
• China: Holds 17% of global demand, with 20% domestic share and CAGR of 7.6%, fueled by government-backed surgical programs.
• India: Represents 14% of global foldable IOL procedures, 19% market share domestically, and CAGR of 7.1%, supported by 1.2 million surgeries yearly.
• Germany: Accounts for 10% of foldable IOL demand, holding 12% market share and CAGR of 5.7%, with growing preference in private hospitals.
• Japan: Contributes 9% to global usage, holding 11% market share domestically and CAGR of 5.6%, reflecting high adoption among elderly populations.

Others

The “Others” category, including femtosecond laser systems, viscoelastic devices, and ophthalmic surgical instruments, represents 17% of the Cataract Surgery Device Market. Approximately 29% of advanced hospitals worldwide have installed femtosecond laser systems, and 33% report increased usage of viscoelastic materials. Around 21% of surgeries in Europe utilize femtosecond technology, compared to 14% in Asia-Pacific. This segment continues to expand as 26% of new device development since 2023 falls under this category.

Value Line: The Others segment holds 17% market share with a CAGR of 5.9%, reflecting strong growth in advanced device categories beyond traditional lenses.

Top 5 Major Dominant Countries in the Others Segment

• United States: Accounts for 42% of global femtosecond laser usage, with 49% national share and CAGR of 6.0%, reflecting high adoption in advanced surgical centers.
• France: Holds 11% of European demand, with 13% share domestically and CAGR of 5.7%, driven by modernization in ophthalmic hospitals.
• China: Represents 15% of global share, with 18% domestic usage and CAGR of 6.5%, fueled by demand for laser-based cataract surgery.
• India: Accounts for 12% of “Others” devices, holding 15% market share and CAGR of 6.8%, supported by growing installation of surgical lasers.
• Japan: Holds 10% global contribution, with 12% domestic market share and CAGR of 5.4%, reflecting strong adoption of precision devices.

By Application

Hospital

Hospitals account for 61% of cataract surgeries worldwide, with more than 17 million procedures performed annually. Around 70% of hospitals in North America and Europe use advanced phacoemulsification systems, while 42% of hospitals in Asia-Pacific have adopted femtosecond-assisted cataract surgery. With 65% of premium intraocular lenses implanted in hospitals, they remain the leading application segment.

Value Line: Hospitals hold 61% market share in cataract surgery devices with CAGR of 6.3%, representing the most dominant application globally.

Top 5 Major Dominant Countries in the Hospital Application

• United States: Hospitals account for 44% of device use nationally, with 53% market share and CAGR of 6.1%, performing 2.6 million procedures annually.
• China: Holds 18% hospital market share, with 21% domestic usage and CAGR of 7.5%, representing nearly 1.8 million annual procedures.
• India: Represents 16% hospital demand, 19% national share, and CAGR of 7.0%, performing over 1.6 million cataract surgeries annually.
• Germany: Accounts for 10% of European hospital demand, with 12% market share and CAGR of 5.9%, performing over 400,000 annual procedures.
• Japan: Holds 9% hospital demand, with 11% market share and CAGR of 5.5%, conducting 380,000 cataract surgeries annually.

Clinic

Clinics contribute 28% of cataract surgeries, performing over 8 million procedures annually worldwide. More than 55% of clinics in developed nations use foldable IOLs, while 43% in emerging economies continue to use standard lenses. Approximately 29% of clinics globally report adopting femtosecond-assisted surgeries, showing steady technological growth.

Value Line: Clinics hold 28% market share in cataract surgery devices with CAGR of 6.4%, representing steady adoption across developed and developing economies.

Top 5 Major Dominant Countries in the Clinic Application

• United States: Clinics account for 36% of procedures nationally, with 44% market share and CAGR of 6.2%, reflecting 1.4 million cataract surgeries yearly.
• India: Represents 17% of clinic procedures, with 19% market share and CAGR of 7.1%, performing nearly 900,000 surgeries annually.
• China: Contributes 15% of global clinic procedures, with 18% domestic share and CAGR of 7.3%, performing over 1 million surgeries annually.
• Germany: Holds 12% of European clinic demand, with 14% share and CAGR of 5.8%, performing nearly 300,000 procedures annually.
• Japan: Accounts for 10% of clinic procedures, with 12% market share and CAGR of 5.6%, representing 270,000 surgeries annually.

Others

Other facilities, including ambulatory surgical centers and private eye hospitals, contribute 11% of cataract surgery device usage, with over 3 million procedures annually. Approximately 47% of ambulatory centers in the USA and 38% in Europe report significant adoption of advanced cataract devices. Around 24% of procedures in Asia-Pacific occur in private specialty centers, reflecting broader availability of cataract care.

Value Line: The Others application segment holds 11% market share with CAGR of 5.8%, reflecting rising adoption of ambulatory surgical centers and specialty eye care units globally.

Top 5 Major Dominant Countries in the Others Application

• United States: Others account for 29% of outpatient procedures nationally, with 35% share and CAGR of 5.9%, performing nearly 900,000 annual cataract surgeries.
• China: Represents 18% of other application procedures, with 21% domestic share and CAGR of 6.5%, performing over 600,000 surgeries annually.
• India: Contributes 15% of other segment demand, with 18% share and CAGR of 6.7%, representing 500,000 procedures annually.
• United Kingdom: Holds 9% of European outpatient demand, with 11% share and CAGR of 5.4%, performing nearly 200,000 procedures annually.
• Japan: Accounts for 8% of other application demand, with 10% share and CAGR of 5.3%, representing 180,000 surgeries annually.

Cataract Surgery Device Market Regional Outlook

The Cataract Surgery Device Market demonstrates diverse regional performance, with North America holding 39% market share, Europe contributing 31%, Asia-Pacific accounting for 25%, and the Middle East & Africa representing 5%. Each region reflects unique adoption trends shaped by demographics, infrastructure, and technology. Over 46% of premium intraocular lenses are consumed in North America, while 37% of femtosecond laser installations occur in Europe. Asia-Pacific leads in surgical volume with nearly 14 million annual cataract procedures, representing 42% of the global total. The Middle East & Africa show strong growth, with 18% of patients still untreated, creating future opportunities.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America accounts for 39% of the Cataract Surgery Device Market, with more than 7 million surgeries annually. Hospitals perform 68% of these procedures, while clinics and ambulatory centers contribute 32%. Premium intraocular lenses represent 49% of total device demand. Approximately 54% of ophthalmologists in the region prefer femtosecond laser-assisted surgeries, while 62% of hospitals utilize foldable IOLs. Adoption of AI-integrated surgical planning has grown by 41% since 2023, and 38% of new device installations involve robotic systems. The market is supported by strong healthcare infrastructure and patient awareness.

Value Line: North America holds 39% market share in cataract surgery devices with steady expansion, and its CAGR is 6.1%, supported by advanced technology adoption and a rising aging population.

North America - Major Dominant Countries in the “Cataract Surgery Device Market”

• United States: Holds 67% of North America’s market share with a CAGR of 6.2%, accounting for nearly 4.7 million annual cataract procedures across hospitals and clinics nationwide.
• Canada: Accounts for 14% of North America’s cataract device usage, with 16% market share and CAGR of 5.8%, representing over 850,000 annual procedures.
• Mexico: Holds 8% regional share with CAGR of 6.5%, performing nearly 600,000 cataract surgeries annually across hospitals and specialty eye clinics.
• Cuba: Accounts for 6% regional share, with CAGR of 5.9% and more than 400,000 surgeries performed annually through government-supported programs.
• Puerto Rico: Holds 5% of regional usage, with CAGR of 5.7% and approximately 350,000 procedures annually in specialty hospitals and ambulatory centers.

Europe

Europe contributes 31% of the Cataract Surgery Device Market, with over 9 million cataract surgeries annually. Approximately 61% of European hospitals use foldable intraocular lenses, while 43% of procedures utilize femtosecond-assisted technologies. Premium intraocular lenses represent 42% of European demand. Adoption of digital imaging devices has increased by 36% since 2023, and 29% of procedures now include AI-assisted planning. Europe’s strong public healthcare system supports high accessibility, with more than 85% of cataract surgeries funded through insurance or national programs.

Value Line: Europe accounts for 31% market share in cataract surgery devices with steady growth, and its CAGR is 5.9%, supported by advanced infrastructure and high accessibility across public healthcare systems.

Europe - Major Dominant Countries in the “Cataract Surgery Device Market”

• Germany: Represents 18% of Europe’s market, holding 12% global share with CAGR of 5.8%, performing over 900,000 annual surgeries with high premium lens adoption.
• United Kingdom: Holds 14% of Europe’s market, with 10% global share and CAGR of 5.7%, accounting for nearly 800,000 cataract procedures annually.
• France: Accounts for 12% of Europe’s demand, holding 9% global share with CAGR of 5.6%, performing approximately 700,000 annual cataract surgeries.
• Italy: Holds 10% European share, with CAGR of 5.5% and 600,000 surgeries performed annually in hospitals and clinics nationwide.
• Spain: Represents 9% of Europe’s market, with CAGR of 5.4% and 550,000 cataract surgeries performed annually.

Asia-Pacific

Asia-Pacific holds 25% of the Cataract Surgery Device Market, performing more than 14 million procedures annually, the highest surgical volume globally. Approximately 39% of patients still suffer from untreated cataracts, creating significant demand potential. Foldable IOL adoption is rising, with 44% of surgeries using them. Premium intraocular lenses represent 31% of regional usage. More than 28% of new hospital investments in the region target ophthalmology departments. Adoption of robotic systems is growing, with 19% of large hospitals already implementing them. Government initiatives in India and China account for 33% of growth in cataract care infrastructure.

Value Line: Asia-Pacific holds 25% of cataract surgery device market share with robust growth, and its CAGR is 7.3%, reflecting rising procedures, population aging, and government-supported healthcare programs.

Asia - Major Dominant Countries in the “Cataract Surgery Device Market”

• China: Represents 19% of Asia’s market, with 15% global share and CAGR of 7.8%, performing over 4 million annual cataract surgeries.
• India: Accounts for 17% of Asia’s market, with 14% global share and CAGR of 7.1%, representing 3.2 million procedures annually.
• Japan: Holds 14% of Asia’s market, with 11% global share and CAGR of 6.0%, performing 1.9 million annual surgeries.
• South Korea: Represents 10% of Asia’s market, with 7% global share and CAGR of 6.8%, accounting for 1.3 million cataract surgeries annually.
• Australia: Holds 9% of Asia’s demand, with 6% global share and CAGR of 6.3%, representing 1.1 million surgeries annually.

Middle East & Africa

The Middle East & Africa hold 5% of the Cataract Surgery Device Market, performing nearly 2 million surgeries annually. Approximately 18% of the regional population remains untreated, reflecting unmet demand. Hospitals account for 63% of procedures, while clinics and specialty centers contribute 37%. Premium intraocular lenses represent 21% of device usage. Government programs in Africa have increased access to cataract surgeries by 26% since 2023. In the Middle East, more than 48% of new hospitals are equipped with advanced phacoemulsification systems, driving adoption of modern devices.

Value Line: The Middle East & Africa hold 5% of cataract surgery device market share with emerging expansion, and its CAGR is 6.4%, reflecting rising healthcare investments and unmet cataract treatment needs.

Middle East and Africa - Major Dominant Countries in the “Cataract Surgery Device Market”

• Saudi Arabia: Holds 16% of the regional market, with CAGR of 6.2%, performing 380,000 cataract surgeries annually across hospitals and specialty clinics.
• South Africa: Represents 14% of regional share, with CAGR of 6.0%, performing nearly 320,000 surgeries annually.
• United Arab Emirates: Accounts for 13% of the regional market, with CAGR of 6.3% and 280,000 annual procedures performed in advanced hospitals.
• Egypt: Holds 12% of regional share, with CAGR of 5.9% and approximately 250,000 cataract surgeries annually.
• Nigeria: Represents 11% of the regional market, with CAGR of 6.1%, performing 220,000 cataract surgeries annually.

List of Top Cataract Surgery Device Companies

• Essilor International
• Alcon, Inc.
• CooperVision Inc
• Bausch & Lomb Inc
• Johnson & Johnson Vision Care Inc
• Carl Zeiss AG
• Abbott Medical Optics Inc
• Hoya Corporation

Top two companies with highest share

• Alcon, Inc.: leads the Cataract Surgery Device Market with approximately 21% global share, distributing over 6 million intraocular lenses and phacoemulsification systems annually across hospitals and clinics in more than 100 countries.
• Johnson & Johnson Vision Care Inc.: follows as the second-largest, holding around 19% global share, supplying premium intraocular lenses and foldable IOLs to more than 4.5 million patients worldwide every year through a robust distribution network.

Investment Analysis and Opportunities

Investments in the Cataract Surgery Device Market are growing rapidly, with more than 34% of total ophthalmic funding allocated to cataract-related technologies since 2023. Approximately 47% of hospital budgets for ophthalmology go to device procurement. Venture capital investments in AI-driven cataract diagnostic tools have increased by 39% over the past two years. Emerging markets present strong opportunities, with Asia-Pacific attracting 31% of global investments in cataract care infrastructure. Government initiatives contribute to 28% of funding allocations, focusing on device modernization. Strategic partnerships between hospitals and manufacturers have grown by 41%, enhancing technology penetration and adoption. Private investments into premium intraocular lens development have risen by 36%, reflecting rising patient demand.

New Product Development

Innovation in the Cataract Surgery Device Market is reshaping patient outcomes. Over 29% of device launches since 2023 feature femtosecond laser integration, while 34% focus on premium intraocular lenses with improved optical performance. AI-powered surgical planning tools represent 23% of recent launches, with adoption rates growing annually. More than 31% of new products aim to reduce surgical time by 20% or more, while 28% prioritize patient comfort and faster recovery. Companies are also developing bio-compatible intraocular lenses with 15% better durability compared to traditional options. Robotic-assisted cataract devices have increased adoption by 19% since 2024, showing strong innovation in automation.

Five Recent Developments (2023–2025)

• 2023: Alcon launched a premium intraocular lens with 17% higher optical clarity, adopted by 230 hospitals within one year.
• 2023: Johnson & Johnson Vision Care introduced a foldable IOL with 22% faster recovery, reaching 180,000 patients in its first year.
• 2024: Carl Zeiss AG developed a femtosecond laser system with 20% shorter procedure time, installed in 120 hospitals worldwide.
• 2024: Essilor International unveiled AI-integrated cataract planning software with 24% improved accuracy, adopted by 300 clinics.
• 2025: Hoya Corporation introduced a next-gen intraocular lens with 18% wider vision correction, targeting 1 million patients globally.

Report Coverage of Cataract Surgery Device Market

The Cataract Surgery Device Market Report provides comprehensive analysis across types, applications, and regions, covering more than 45 countries worldwide. The study includes device categories such as intraocular lenses, foldable IOLs, femtosecond lasers, viscoelastic materials, and related surgical instruments. Market segmentation highlights applications in hospitals, clinics, and ambulatory centers, reflecting diverse usage patterns. The report provides insights into regional performance, with North America holding 39% market share, Europe 31%, Asia-Pacific 25%, and Middle East & Africa 5%. Company profiling includes leading manufacturers controlling over 62% of the market. Investment trends, new product development, and competitive dynamics are also examined, supported by 2023–2025 recent developments. With detailed segmentation and forecast insights, the Cataract Surgery Device Market Report serves as a reliable reference for B2B stakeholders seeking market opportunities, industry growth patterns, and global distribution strategies.

Cataract Surgery Device Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 4415.33 Million in 2026
Market Size Value By	USD 6443.77 Million by 2035
Growth Rate	CAGR of 4.29% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Intraocular Lens Foldable IOL Others By Application : Hospital Clinic Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample